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Abstract 
Introduction:  To describe the characteristics, diagnosis, and treatment of the first documented case of Vogt–Koy-
anagi–Harada (VKH) disease following BCG vaccination (Patient 1) and the first documented case of both VKH disease 
and tuberculosis (Patient 2).
Two patients were diagnosed with VKH disease and monitored using fundus photography, fundus autofluorescence, 
fluorescein angiography (FA), spectral-domain optical coherence tomography, and enhanced depth imaging optical 
coherence tomography (EDI-OCT).
Case description:  A 39-year-old patient (Patient 1) had bilateral granulomatous anterior uveitis and serous retinal 
detachment. FA showed multiple punctuate hyperfluorescent lesions and multilobular pools of dye. EDI-OCT revealed 
serous retinal detachment, subretinal septa, and cystoid spaces. A 40-year-old woman (Patient 2) presented with a 
3-week history of decreased vision, headache and tinnitus. Fundus examination showed bilateral disc swelling with 
serous retinal detachment and retinal folds. She had been diagnosed with tuberculosis. EDI-OCT showed fluctuation 
of the internal limiting membrane (ILM), retinal folds, retinal pigment epithelial (RPE)-Bruch membrane undulation, 
choroidal folds, serous retinal detachment. Both of the patients received high dosage of steroid treatment during the 
diagnosis. A fast recovery in VKH symptoms was observed following the treatment.
Discussion and evaluation: Immunological mechanisms and dysregulation of the immune system may play a 
significant role in the association between VKH disease and BCG.
Conclusions: EDI-OCT imaging demonstrated structural changes in the photoreceptor layer, RPE-Bruch membrane, 
choroid, outer retina, ILM in acute VKH.
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Background
Vogt–Koyanagi–Harada (VKH) disease is a rare granu-
lomatous inflammatory disorder affecting the eyes, audi-
tory system, meninges and skin. The precise etiology 
and pathogenesis of VKH disease are unknown, but cur-
rent clinical and experimental evidence suggests a cell-
mediated autoimmune process driven by T-lymphocytes 
directed against self-antigens associated with melano-
cytes in genetically susceptible individuals (Moorthy et al. 
1995; Rao 1997). Typical clinical features of VKH include 
bilateral panuveitis associated with exudative retinal 
detachment, meningism associated with headache and 
pleocytosis of cerebrospinal fluid, tinnitus or hearing loss, 
and cutaneous changes, such as alopecia, poliosis, and 
vitiligo. Presence of ocular and two or more extraocular 
features is considered as a complete form of VKH disease. 
Incomplete VKH disease includes bilateral typical ocular 
involvement plus either neurologic/auditory or cutaneous 
changes, whereas probable VKH disease is composed of 
just ocular manifestations. However, some of these prob-
able VKH patients can develop cutaneous manifestations 
during the chronic or chronic recurrent stage of the dis-
ease. The acute phase of the VKH disease is characterized 
by bilateral uveitis, diffuse choroidal inflammation, and 
multifocal serous retinal detachment (Read et  al. 2001). 
During this phase, the neural retina is detached from the 
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retinal pigment epithelium (RPE), the subretinal space 
is filled with an eosinophilic exudate of proteinaceous 
material, and the choroid is diffusely infiltrated by lym-
phocytes, with focal aggregates of epithelioid histiocytes 
and multinucleated giant cells. These histologic changes 
during the acute phase have been observed to incur early 
damage to choroidal melanocytes. Immunohistochemi-
cal analysis has also revealed that the choroidal infiltrates 
observed during this phase are predominantly comprised 
of T-lymphocytes (Rao 2007).
The chronic phase in which progressive choroidal 
depigmentation occurs results in a change classically 
described as sunset glow fundus. During this stage, viti-
ligo and poliosis may occur (Moorthy et  al. 1995; Read 
et al. 2001), and some patients may develop vision-threat-
ening retinal complications, including choroidal neovas-
cularization and subretinal fibrosis (Read et al. 2001).
Enhanced depth imaging optical coherence tomogra-
phy (EDI-OCT) and fluorescein angiography (FA) are of 
great importance in diagnosis of VKH disease, monitor-
ing of morphological changes in the retina and choroid 
during its course, and evaluation of the efficacy of oph-
thalmologic therapies (Ishihara et  al. 2009). Using EDI-
OCT, disruption of the outer retina, especially of the 
inner/outer segment (IS/OS) junction, and of the cone 
outer segment tips (COST) line, as well as irregularities 
of the RPE layer, have been observed in acute VKH dis-
ease (Gupta et al. 2009; Vasconcelos-Santos et al. 2010).
Case description
Patient 1 was a 39-year old Caucasian male who had been 
diagnosed with superficial transitional cell carcinoma 
(TCC) of the bladder in 2015. He was initially treated 
with intravesical immunotherapy consisting of weekly 
instillations of BCG for a total of 4  weeks. After the 
fourth dosage of BCG treatment had been administered, 
he was admitted to our clinic complaining of blurred 
vision in both eyes, headache and malaise. Neurologic 
examination was nonrevealing. Brain magnetic resonance 
imaging (MRI) was normal. His angiotensin-converting 
enzyme (ACE) level was normal, and serological testing 
for syphilis, Lyme disease, cytomegalovirus (CMV), and 
toxoplasma was negative. His best-corrected visual acuity 
(BCVA) was 20/25 in the right eye (OD) and 20/50 in the 
left eye (OS). Slit-lamp biomicroscopy showed anterior 
chamber cells. Left eye had serous retinal detachment in 
the posterior fundus (Fig. 1b). Early-phase FA of the left 
eye showed multiple punctuate hyperfluorescent lesions 
on the RPE and multiple small round hypofluorescent 
lesions, suggesting an uneven filling of the choriocapilla-
ris (Fig. 1d). Mid-phase FA and late-phase FA of the left 
eye showed multilobular pools of dye (Fig.  1e, f ). EDI-
OCT of the left eye revealed serous retinal detachment, 
subretinal septa, cystoid spaces, and choroidal hyperre-
flectivity (Fig. 1h). The subretinal septa was a portion of 
the outer segment (OS) layer separated from the inner 
segment (IS) layer by cystoid spaces. The subretinal cys-
toid spaces were mildly reflective, whereas the areas of 
serous retinal detachment were not reflective.
Based on these observations, the patient was treated 
with 1 mg/kg/day of oral prednisone that was gradually 
tapered off over 6 months.
Four days after initiation of steroid therapy, the serous 
retinal detachment was resolved in the left eye (Fig.  2b). 
Whereas late-phase FA of the right eye showed hyperfluo-
rescent dots (Fig. 2c), late-phase FA of the left eye showed a 
decrease in multiple punctuate hyperfluorescent lesions and 
multilobular pools of dye (Fig. 2d). Ten days after initiation 
of steroid therapy, late-phase FA of the right eye showed 
an increase in multilobular pools of dye, while late-phase 
FA of the left eye showed a decrease in multiple punctu-
ate hyperfluorescent lesions and multilobular pools of dye 
(Fig. 2e, f). EDI-OCT of the right eye showed serous retinal 
detachment, subretinal cystoid spaces, and subretinal septa 
separating the cystoid space from subretinal fluid (Fig. 2g). 
EDI-OCT of the left eye showed a decrease in serous retinal 
detachment, and the subretinal cystoid spaces completely 
resolved. EDI-OCT revealed hyper-reflective lesions at the 
level of the retinal pigment epithelium with disruption of 
the IS/OS line (Dalen-Fuchs nodule), and disappearance of 
the COST line and the IS/OS junction and the vertical lining 
on the outer plexiform layer (Fig. 2h). One month after the 
start of steroid therapy, best-corrected visual acuity (BCVA) 
was 20/20 in both eyes (Fig. 3). 
Patient 2 was a 40-year old darkly pigmently Caucasian 
female admitted to our clinic in July 2015 complaining 
(See figure on next page.) 
Fig. 1 Images of the right eye and left eye of Patient 1 at diagnosis of VKH disease. a, b Color fundus photograph. Left eye shows serous retinal 
detachment. c Early-phase fluorescein angiogram (FA) of the right eye shows hyperfluorescent dots. d Early-phase FA of the left eye shows multiple 
punctuate hyperfluorescent lesions on the retinal pigment epithelium (RPE) and multiple small round hypofluorescent lesions, suggesting uneven 
filling of the choriocapillaris (dark areas). e, f Mid-phase FA (2 min) and late-phase FA (7 min) of the left eye shows multilobular pools of dye. Foveal 
round area of the dye pooling has a dark rim. g Enhanced depth imaging optical coherence tomography (EDI-0CT) of the right eye shows choroidal 
hyperreflectivity. Chroidal thickness = 436 µm (OD). h EDI-OCT of the left eye shows serous retinal detachment, subretinal cystoid spaces, and sub-
retinal septa (white arrow) separating the cystoid space from subretinal fluid. The subretinal cystoid spaces are slightly more reflective than the area 
of serous retinal detachment. Retinal thickness = 1246 µm (OS). Enlargement of the choroid of the left eye is not visible on EDI-OCT at this stage
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of blurred vision in both eyes and optic disc edema. She 
had been referred by the neurology clinic, which had 
been monitoring her for the past 3 weeks for complaints 
of malaise, headache, and tinnitus. Lumbar puncture 
revealed sterile cerebrospinal fluid lymphocytic pleo-
cytosis. Level of angiotensin-converting enzyme (ACE) 
was normal; the results of serological testing for syphilis, 
Lyme disease, herpes simplex virus, varicella zoster virus, 
cytomegalovirus, and toxoplasma was negative; and brain 
magnetic resonance imaging was normal. In her previ-
ous medical history, she had been diagnosed with tuber-
culosis and had been treated for 9 months. At diagnosis, 
her BCVA was 20/50 in the right eye (OD) and 20/32 in 
the left eye (OS). Slit-lamp biomicroscopy showed bilat-
eral anterior chamber cells. Intraocular pressure was 
13 mm Hg OU.
Fundus examination showed bilateral optic disc swell-
ing with serous retinal detachment and retinal folds 
(Fig.  4a, b). Early-phase FA showed multiple punctu-
ate hyperfluorescent lesions on the RPE and optic disc 
hyperfluorescence (Fig.  4c, d). Late-phase FA showed 
multilobular pools of dye (Fig. 5a, b). Fundus autofluores-
cence (FAF) revealed mixed hypo-hyperautofluorescence 
(Fig.  5c, d). EDI-OCT showed fluctuation of internal 
limiting membrane (ILM), retinal folds, RPE-Bruch 
membrane undulation, choroidal folds, and serous reti-
nal detachment. The choroid was enlarged and not vis-
ible on EDI-OCT at this stage (Fig. 5e, f ). Based on these 
findings, administration of 1  mg/kg/day of prednisone 
was initiated, and then gradually tapered over 6 months. 
The effects of the treatment were monitored with weekly 
EDI-OCT imaging until resolution of serous retinal 
detachment.
Eight days after initiation of steroid therapy, serous 
retinal detachment and disc swelling resolved (Fig.  6a, 
b). Mid-phase FA showed decrease in multiple punctu-
ate hyperfluorescent lesions and multilobular pools of 
dye (Fig. 6c, d). EDI-OCT showed decrease in fluctuation 
internal limiting membrane, retinal folds, RPE-Bruch 
membrane undulation, choroidal folds, and serous reti-
nal detachment (Fig. 6e, f ). Three months after the start 
of steroid therapy, color fundus photos showed disap-
pearance of serous retinal detachment with disc swelling 
and retinal folds (Fig.  7a, b), FA showed minimal optic 
disc hyperfluorescence (Fig.  7c, d), and EDI-OCT con-
firmed complete resolution of serous retinal detachment 
and RPE-Bruch membrane undulation (Fig.  7e, f ). Her 
best-corrected visual acuity (BCVA) was 20/20 in both 
eyes. About 2–3 months after the onset of VKH, vitiligo 
occurred on the face.
Discussion
The OCT findings of previous research have confirmed 
that the densest tissue affected by the inflammatory pro-
cess in VKH disease is the choroid. Previous studies have 
also observed that the outer retina, IS/OS junction, RPE, 
and vitreous are also affected by inflammation (Vascon-
celos-Santos et al. 2010; Lee et al. 2009; Zhou et al. 2015). 
These findings indicate the existence of an immune 
mechanism against melanocytes accompanied by anti-
genic peptides accompany and managed by T-lympho-
cytes (Rao 1997).
Immunotherapy against superficial bladder cancer can 
be created by administration of BCG vaccine, which trig-
gers a cytokine-mediated inflammatory response leading 
to the destruction of tumor cells (Uppal et al. 2010).
However, intravesical BCG therapy has been impli-
cated in the development of anterior uveitis in several 
case reports. The mechanism behind this phenomenon is 
immune sensitization revealed by BCG with cross-reac-
tion against the ocular antigen. Bilateral panuveitis (Jacob 
et  al. 2006), chorioretinitis (Guex-Crosier et  al. 2003), 
and/or optic neuritis (Hegde and Dean 2005) are rarely 
seen in patients, and mycobacterial choroiditis has been 
reported in only two previous case reports (Guex-Crosier 
et al. 2003).
There are two mechanisms that can be suggested 
for the origin of ocular inflammation: a local immune 
response, or a direct choroidal mycobacterial infection 
as demonstrated by vitreous cultures (Uppal et al. 2010). 
Burgoyne described the case of a 16-year-old Caucasian 
girl known not to have tuberculosis or any other systemic 
(See figure on previous page) 
Fig. 2 Images of the right eye and left eye of Patient 1. a, b Four days after initiation of steroid therapy, serous retinal detachment has been 
resolved in the left eye. c Late-phase FA (18 min) of the right eye shows hyperfluorescent dots. d Late-phase FA (18 min) of the left eye shows 
decrease in multiple punctuate hyperfluorescent lesions and multilobular pools of dye. e, f Ten days after initiation of steroid therapy, late-phase 
FA (9 min) of the right eye shows increase in multilobular pools of dye. Late-phase FA (7 min) of the left eye shows decrease in multiple punctuate 
hyperfluorescent lesions. g EDI-OCT image of the right eye shows serous retinal detachment, subretinal cystoid spaces, and subretinal septa separat-
ing the cystoid space from subretinal fluid. Chroidal thickness = 564 µm. h EDI-OCT image of the left eye shows decrease in serous retinal detach-
ment and complete resolution of subretinal cystoid spaces. EDI-OCT reveals hyper-reflective lesions at the level of the retinal pigment epithelium 
(RPE) with disruption of the inner segment/outer segment (IS/OS) line (Dalen-Fuchs nodule) (red arrow) and discontinuous IS/OS line (white arrow). 
Choroidal thickness = 541 µm
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disease who developed acute panuveitis that progressed 
to bilateral serous retinal detachment after undergoing 
two sessions of purified protein derivative (PPD) skin 
testing separated by an interval of 8 years (Burgoyne et al. 
1991).
A strong T-helper 1 response, which is known to be the 
most frequent type of immune response associated with 
uveitis, is induced by M. tuberculosis. Panuveitis is pri-
marily caused by tuberculosis, VKH syndrome, sympa-
thetic ophthalmia, Behcet’s disease, and sarcoidosis.
Fig. 3 Images of the right eye and left eye of Patient 1. a, b Color fundus photos 1 month after initiation of steroid therapy. c, d EDI-OCT 1 month 
after initiation of steroid therapy. Choroidal thickness = 414 µm (OD) and 458 µm (OS). e, f FA 1 month after initiation of steroid therapy
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Uveitis, serous retinal detachment, and VKH may 
be potentially caused by antigenic mimicry. Investiga-
tion of the highest Th1 responses with the sequences of 
BCG proteins induced by the comparison of the amino 
acid sequences of retinal proteins and peptides identified 
several highly similar or even identical regions of 5–11 
amino acids. Crossreactivity of the patient’s BCG-specific 
T cells with retinal autoantigen might have been caused 
by these epitopes. The previously reported uveitis was 
presumed to be caused by this phenomenon, referred to 
as antigenic mimicry (Garip et al. 2009).
BCG toxicity might be an expected result of immune 
stimulation and it proves that BCG is effective. Role of 
immune stimulation in the pathogenesis of VKH support 
this relationship.
EDI-OCT revealed our patients with acute VKH, 
increased choroidal thickness, RPE-Bruch membrane 
undulation, fluctuation of ILM, choroidal folds, reti-
nal folds, vertical lining on the outer plexiform layer, 
increased choroidal hyperreflectivity, serous retinal 
detachment, Dalen-Fuchs nodules, and subretinal septa. 
To the best of our knowledge, this is the first report of 
DF nodules imaged by EDI-OCT in VKH. Previous study 
revealed focal collections of mononuclear inflammatory 
cells under elevated mounds of RPE led to the formation 
of Dalen-Fuchs nodules consisting of lymphocytes, pig-
ment-laden macrophages, epithelioid cells, and prolifer-
ated RPE cells (Rao 2007).
The RPE undulation index was first described by 
Hosoda et al. (2014) and it was observed on the SD-OCT 
Fig. 4 Images of the right and left eyes of Patient 2 at diagnosis of VKH disease. a, b Color fundus photos show bilateral disc swelling with serous 
retinal detachment and retinal folds. c, d: Early-phase FA (1 min) shows multiple punctuate hyperfluorescent lesions on the RPE and optic disc 
hyperfluorescence
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images that patients with VKH disease experienced sig-
nificant distortions of the RPE layer. This distortion 
may be due to the choroidal congestion caused by the 
infiltration of inflammatory cells. Lin et  al. (2014) first 
described the ILM fluctuations observed on the SD-
OCT images of acute VKH patients. To the best of our 
Fig. 5 Images of the right and left eyes of Patient 2 at diagnosis of VKH disease. a, b Late-phase FA (12 min) shows multilobular pools of dye. c, d 
Fundus autofluorescence (FAF) reveals mixed hypo-hyperautofluorescence. e, f EDI-OCT shows fluctuation of internal limiting membrane (ILM) (red 
arrow), retinal folds, RPE-Bruch membrane undulation (white arrow), choroidal folds, serous retinal detachment. Retinal thickness = 688 µm (OD) 
and 641 µm (OS). Enlargement of the choroid of the both eyes is not visible on EDI-OCT at this stage
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Fig. 6 Images of the right and left eyes of Patient 2. a, b Eight days after initiation of steroid therapy, serous retinal detachment and disc swelling 
have resolved. c, d Mid-phase FA (3 min) shows decrease in multiple punctuate hyperfluorescent lesions and multilobular pools of dye. e, f EDI-OCT 
shows decrease in fluctuation of ILM, retinal folds, RPE-Bruch membrane undulation, choroidal folds, and serous retinal detachment
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knowledge, patient 2 is the second reported case of ILM 
fluctuation. Although the mechanism of ILM fluctuation 
is not fully known, inflammatory cells in vitreous have 
been hypothesized to cause local constriction of ILM, 
and retina edema to cause ILM fluctuation (Lin et  al. 
2014).
Fig. 7 Images of the right and left eyes of Patient 2. a, b Color fundus photos taken 3 months after initiation of steroid therapy show disappearance 
of serous retinal detachment with disc swelling and retinal folds. c, d FA shows minimal optic disc hyperfluorescence. e, f EDI-OCT shows complete 
resolution of serous retinal detachment and RPE-Bruch membrane undulation. Choroidal thickness = 365 µm (OD) and 346 µm (OS)
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Clusters of T-lymphocytes activated around early cho-
roidal melanocytes and macrophages accumulate abnor-
mally and cause extensive choroidal thickening. VKH, in 
which choroid is the thickest tissue, is one of the main 
pathologies resulting from this phenomenon. In VKH, a 
significant increase in hyperreflective points is observed 
on an area of arterioles and venules, which are the 
medium choroidal vessels (Nazari et al. 2014). One of the 
most important findings of OCT in acute VKH disease 
is the large number of serous retinal detachment areas 
whose height of these may be much higher than those of 
serous retinal detachments in other tables. Although the 
fundus in the right eye of Patient 1 was normal at diag-
nosis, we found the choroid on EDI-OCT to be thick and 
observed increased choroidal hyperreflectivity, which 
indicates the changes concerning the disease. Abnormal 
increase in choroidal thickness causes fluctuations the 
RPE-Bruch membrane. The EDI-OCT images revealed 
that the IS/OS junction and RPE were mainly affected 
(Lee et al. 2009). These impacts included RPE distortions 
and disappearance of the IS/OS junction.
The length of the interval from the onset of symp-
toms to the initiation of the systemic steroid therapy is 
an important prognostic factor for patients with acute 
VKH, for whom proper and prompt treatment is crucial. 
Such treatment may prevent progression of the disease 
to the chronic recurrent stage and may possibly reduce 
the incidence and perhaps the severity of extraocular 
manifestations.
Conclusion
Our findings indicate the importance of considering EDI-
OCT findings, which allowed us to identify the histo-
pathologic changes regarding the disease. To the best of 
our knowledge, patient 1 was the first documented case 
of VKH following BCG vaccination and patient 2 the first 
documented case of both VKH disease and tuberculosis. 
Based on our observations, we hypothesize that immu-
nological mechanisms and dysregulation of the immune 
system may play a significant role in the association 
between VKH disease and BCG.
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